127 related articles for article (PubMed ID: 31293303)
1. Thyroid Cartilage Metastases on F-18 Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: A Tale of Two Cases with a Brief Review of Literature.
Tripathy S; Parida GK; Singhal A; Shamim SA; Kumar R
Indian J Nucl Med; 2019; 34(3):220-222. PubMed ID: 31293303
[TBL] [Abstract][Full Text] [Related]
2. Rare thyroid Cartilage Metastases Detected on
Gupta N; Verma R; Belho ES
Indian J Nucl Med; 2021; 36(1):39-42. PubMed ID: 34040294
[TBL] [Abstract][Full Text] [Related]
3. A Rare Case of Thyroid Cartilage Metastases Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Verma S; Singh MM; Deswal S; Kakkar L
Indian J Nucl Med; 2023; 38(2):172-173. PubMed ID: 37456176
[TBL] [Abstract][Full Text] [Related]
4. Metastatic Thyroid Cartilage Lesion from Prostatic Adenocarcinoma on
Gupta N; Verma R; Belho ES
Indian J Nucl Med; 2021; 36(2):183-188. PubMed ID: 34385791
[TBL] [Abstract][Full Text] [Related]
5. Rare Thyroid Cartilage and Diaphragm Metastases from Lung Cancer Visualized on F-18 FDG-PET/CT Imaging.
Ozcan Kara P; Kara Gedik G; Sarı O; Ozbek O
Mol Imaging Radionucl Ther; 2011 Aug; 20(2):70-2. PubMed ID: 23486533
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
8. F-18 FDG PET/CT imaging in the diagnostic work-up of thyroid cancer patients with high serum thyroglobulin, negative I-131 whole body scan and suppressed thyrotropin: 8-year experience.
Elboga U; Karaoglan H; Sahin E; Kalender E; Demir HD; Basıbuyuk M; Zeki Celen Y; Yilmaz M; Ozkaya M
Eur Rev Med Pharmacol Sci; 2015; 19(3):396-401. PubMed ID: 25720709
[TBL] [Abstract][Full Text] [Related]
9. Presentation of Unusual Tracheal Metastasis on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography after 9 Years in Postnephrectomy Patient of Renal Cell Carcinoma: A Case Report and Review of Literature.
Parghane RV; Sood A; Vaiphei K; Aggarwal AN; Mittal BR
World J Nucl Med; 2017; 16(3):240-242. PubMed ID: 28670185
[TBL] [Abstract][Full Text] [Related]
10. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
11. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Metastasis from Visceral Organs:
Gupta N; Malik D; Verma R; Belho ES; Manocha A
Indian J Nucl Med; 2019; 34(3):205-208. PubMed ID: 31293299
[TBL] [Abstract][Full Text] [Related]
13. ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature.
Lauridsen JK; Rohde M; Thomassen A
PET Clin; 2015 Jan; 10(1):75-88. PubMed ID: 25455881
[TBL] [Abstract][Full Text] [Related]
14. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
15. Case report of
Zhao H; Lin C; Jiao B; Sa R; Hou S; Xu S
Thorac Cancer; 2018 Jan; 9(1):167-170. PubMed ID: 28980762
[TBL] [Abstract][Full Text] [Related]
16. F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
Hung MC; Wu HS; Kao CH; Chen WK; Changlai SP
Endocr Res; 2003 May; 29(2):169-75. PubMed ID: 12856803
[TBL] [Abstract][Full Text] [Related]
17. Late recurrence of a papillary thyroid carcinoma 37 years after hemithyroidectomy: Solitary, left cervical lymph node metastasis evident on fluorodeoxyglucose positron-emission tomography/computed tomography images revealing nodular uptake.
Kunogi H; Naoi Y; Matsumoto T; Ozaki Y
World J Nucl Med; 2020; 19(2):155-158. PubMed ID: 32939207
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
Hooft L; Hoekstra OS; Devillé W; Lips P; Teule GJ; Boers M; van Tulder MW
J Clin Endocrinol Metab; 2001 Aug; 86(8):3779-86. PubMed ID: 11502811
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
20. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
